reference/23115878

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23115878

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	516
issn	0008-543X 1097-0142
issueIdentifier	3
pageRange	509-516
publicationName	Cancer
startingPage	509
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_42f7153bebbc1ab0c252d0652b9ef898 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7accf05af2989754d19a209796945038 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c975659c912b1d802402cca8e0016b17
bibliographicCitation	Curran WJ, Krisch R, Cox JD, Azarnia N, Pajak TJ, Byhardt RW, Shin KH, Emani B, Phillips TL, Selim H, Herskovic A, Mohiuddin M, Ager PJ, Scotte Doggett RL. Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83-11. Cancer. 1991 Aug 01;68(3):509–16. doi: 10.1002/1097-0142(19910801)68:3<509::aid-cncr2820680311>3.0.co;2-7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3687d1bf8b398ce5180bbd49fe4a1cbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c027589bdb7e1f51fca6c38b3ad0fcc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ebade4c2494c40a558d2202343297f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_578748b0954d72380474b8068a7f29c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3864970dbe8d2923a59acd8d5824b31e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de6f3561d2b1a8d9b9a8dcf3ef244a92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e382ec1d2871e8c812b7158e1d97b2cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95258226ca0e503681407f5c28f241e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e78208d1bf35ae3c86b97157c9683cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec735b89f0c0c497d9adf0ea1467805e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_feb6cf02b50d5efdae63bffee3b109d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7c6ef307221a740615ec76cc8217c77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e6c8b7aa18c8577927e9a8e58d8aca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dbc0bb285d5a977e51e0aed606b4ee7
date	1991-08-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/1097-0142%2819910801%2968:3%3C509::aid-cncr2820680311%3E3.0.co%3B2-7 https://pubmed.ncbi.nlm.nih.gov/1648432
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/1097-0142 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83-11
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000532 http://id.nlm.nih.gov/mesh/D008175Q000532 http://id.nlm.nih.gov/mesh/D009367Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D011879 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D013909Q000473 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D009361
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6590

Showing number of triples: 1 to 55 of 55.